Table 3. Association between participants’ demographic, attitude, and their knowledge.
Demographic Characteristics | Knowledge about ARC among participants (N) | Chi-Square p-value | Attitude toward ARC (N) | Chi-square P value | ||||
---|---|---|---|---|---|---|---|---|
Good | Moderate | Poor | Negative | Positive | ||||
Gender | Female | 2 | 13 | 47 | 0.663 | 6 | 56 | 0.267 |
Male | 1 | 4 | 25 | 1 | 29 | |||
Age | Under 35 years | 2 | 7 | 42 | 0.738 | 5 | 46 | 0.872 |
35–44 | 0 | 3 | 13 | 1 | 15 | |||
45–54 | 1 | 4 | 10 | 1 | 14 | |||
55–64 | 0 | 3 | 6 | 0 | 9 | |||
Above 65 | 0 | 0 | 1 | 0 | 1 | |||
Profession | Physician | 3 | 6 | 51 | 0.010* | 6 | 54 | 0.236 |
Clinical pharmacist | 0 | 11 | 21 | 1 | 31 | |||
Specialty | Internal | 1 | 2 | 7 | 0.028* | 0 | 10 | 0.006* |
Pediatric | 0 | 1 | 13 | 2 | 12 | |||
Oncology | 0 | 0 | 10 | 4 | 6 | |||
Cardiology | 0 | 0 | 2 | 0 | 2 | |||
Nephrology | 0 | 1 | 7 | 0 | 8 | |||
Urology | 0 | 1 | 7 | 0 | 8 | |||
ICU | 2 | 1 | 5 | 0 | 8 | |||
Clinical pharmacist | 0 | 11 | 21 | 1 | 31 | |||
Source of information | Academic conferences CME | 0 | 3 | 12 | 0.736 | 0 | 15 | 0.224 |
Research literature | 2 | 5 | 18 | 0.894 | 0 | 25 | 0.020* | |
Social networks | 2 | 2 | 11 | 0.877 | 2 | 13 | 0.585 | |
Hospital guidelines | 0 | 4 | 23 | 0.415 | 1 | 26 | 0.050* | |
Evidence-based resources | 1 | 11 | 26 | 0.094 | 0 | 36 | 0.021* |
* Significance at P value equal to or less than 0.05
ARC, Augmented renal clearance.